The estimated Net Worth of Patrick Holt is at least $186 mil dollars as of 22 January 2024. Patrick Holt owns over 14,426 units of Amarin Corp stock worth over $185,511 and over the last few years Patrick sold AMRN stock worth over $0.
Patrick has made over 2 trades of the Amarin Corp stock since 2023, according to the Form 4 filled with the SEC. Most recently Patrick bought 14,426 units of AMRN stock worth $15,724 on 22 January 2024.
The largest trade Patrick's ever made was buying 300,000 units of Amarin Corp stock on 16 August 2023 worth over $312,000. On average, Patrick trades about 104,809 units every 53 days since 2023. As of 22 January 2024 Patrick still owns at least 314,426 units of Amarin Corp stock.
You can see the complete history of Patrick Holt stock trades at the bottom of the page.
Patrick's mailing address filed with the SEC is C/O AMARIN PHARMA, INC., 440 US HIGHWAY 22, BRIDGEWATER, NJ, 08807.
Over the last 13 years, insiders at Amarin Corp have traded over $25,876,836 worth of Amarin Corp stock and bought 581,426 units worth $751,974 . The most active insiders traders include John F Thero, Steven B Ketchum, eDavid M Stack. On average, Amarin Corp executives and independent directors trade stock every 10 days with the average trade being worth of $29,442. The most recent stock trade was executed by Aaron Berg on 2 August 2024, trading 160,000 units of AMRN stock currently worth $102,400.
amarin corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. vascepa® (icosapent ethyl) is amarin's first fda approved product and is available in the united states by prescription. for more information about vascepa visit www.vascepa.com.
Amarin Corp executives and other stock owners filed with the SEC include: